drug interaction(s) of tofacitinib with shingles vaccine

^[1]

Drug interactions

tofacitinib may interefere with immunological response to the shingles vaccine^[1]
- start tofacitinib 2 weeks after shingles vaccination

↑ ^{Jump up to: 1.0} ^1.1 Winthrop KL, Wouters AG, Choy EH et al. The safety and immunogenicity of live zoster vaccination in patients with rheumatoid arthritis before starting tofacitinib: A randomized phase II trial. Arthritis Rheumatol 2017 Oct; 69:1969 PMID: https://www.ncbi.nlm.nih.gov/pubmed/28845577
Winthrop KL, Curtis JR, Lindsey S et al Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy. Arthritis Rheumatol. 2017 Oct;69(10):1960-1968. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28845604